Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
Investigations into the Manzamine Alkaloid Biosynthetic Hypothesis
Jack E Baldwin, Timothy D W Claridge, Andrew J Culshaw, et al.
Journal of Medicinal Chemistry
|
September 3, 2004
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core
Timothy J Ritchie, Edward K Dziadulewicz, Andrew J Culshaw, et al.
Journal of Veterinary Internal Medicine
|
October 20, 2012
Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study)
N J Summerfield, A Boswood, M R O'Grady, et al.
Journal of Medicinal Chemistry
|
August 30, 2008
Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain
Osamu Irie, Takatoshi Kosaka, Takeru Ehara, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 12, 2008
Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-cyanopyrimidines. Part 2
Osamu Irie, Takatoshi Kosaka, Masashi Kishida, et al.
Journal of Medicinal Chemistry
|
July 17, 2007
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration
Edward K Dziadulewicz, Stuart J Bevan, Christopher T Brain, et al.
Journal of Medicinal Chemistry
|
January 20, 2006
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain
Andrew J Culshaw, Stuart Bevan, Martin Christiansen, et al.
Journal of Medicinal Chemistry
|
February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase
Gebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
Investigations into the Manzamine Alkaloid Biosynthetic Hypothesis
Jack E Baldwin, Timothy D W Claridge, Andrew J Culshaw, et al.
Journal of Medicinal Chemistry
|
September 3, 2004
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core
Timothy J Ritchie, Edward K Dziadulewicz, Andrew J Culshaw, et al.
Journal of Veterinary Internal Medicine
|
October 20, 2012
Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study)
N J Summerfield, A Boswood, M R O'Grady, et al.
Journal of Medicinal Chemistry
|
August 30, 2008
Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain
Osamu Irie, Takatoshi Kosaka, Takeru Ehara, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 12, 2008
Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-cyanopyrimidines. Part 2
Osamu Irie, Takatoshi Kosaka, Masashi Kishida, et al.
Journal of Medicinal Chemistry
|
July 17, 2007
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration
Edward K Dziadulewicz, Stuart J Bevan, Christopher T Brain, et al.
Journal of Medicinal Chemistry
|
January 20, 2006
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain
Andrew J Culshaw, Stuart Bevan, Martin Christiansen, et al.
Journal of Medicinal Chemistry
|
February 17, 2025
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase
Gebhard Thoma, Wolfgang Miltz, Rudolf Waelchli, et al.
Page
of 4